Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Depreciation & Amortization - Total (2016 - 2025)

Historic Depreciation & Amortization - Total for BioCorRx (BICX) over the last 13 years, with Q3 2025 value amounting to $1474.0.

  • BioCorRx's Depreciation & Amortization - Total fell 7704.05% to $1474.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $22076.0, marking a year-over-year decrease of 1402.76%. This contributed to the annual value of $31966.0 for FY2024, which is 2472.59% up from last year.
  • BioCorRx's Depreciation & Amortization - Total amounted to $1474.0 in Q3 2025, which was down 7704.05% from $4130.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Depreciation & Amortization - Total registered a high of $12708.0 during Q4 2024, and its lowest value of $1474.0 during Q3 2025.
  • In the last 5 years, BioCorRx's Depreciation & Amortization - Total had a median value of $6420.0 in 2023 and averaged $6369.1.
  • Per our database at Business Quant, BioCorRx's Depreciation & Amortization - Total soared by 9794.39% in 2024 and then plummeted by 7704.05% in 2025.
  • BioCorRx's Depreciation & Amortization - Total (Quarter) stood at $6567.0 in 2021, then changed by 0.0% to $6567.0 in 2022, then dropped by 2.24% to $6420.0 in 2023, then surged by 97.94% to $12708.0 in 2024, then crashed by 88.4% to $1474.0 in 2025.
  • Its Depreciation & Amortization - Total was $1474.0 in Q3 2025, compared to $4130.0 in Q2 2025 and $3764.0 in Q1 2025.